Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Market Brief: Looking Beyond China And Japan For High Growth And Opportunity In Asian Medtech

Executive Summary

With a combined value of $14.1bn in 2019, there are ten high-growth medtech markets worth watching in Asia.

You may also be interested in...



Asia Reg News: AHWP Catch-Up, Korea, Malaysia, Indonesia and Vietnam Updates

Part 1 of this month’s Asian Medtech Associations Regulatory Networking discussions features Asean medtech market developments and Asian Harmonization Working Party news. Part 2 was a guest presentation on the current Brexit and EU IVDR outlook. This feature is hosted by Medtech Insight, the Asia Regulatory and Quality Consultancy (ARQon) and the Asia Regulatory Professionals Association (ARPA).

Asia Regulatory Roundup, 2018: A Region Full Of Reforms

The ground is shifting across Asia when it comes to how medical devices and diagnostics are regulated. Reforms throughout the region were evident in Medtech Insight's top 15 Asia regulatory and policy stories from 2018.

Korea Outlines Device Regulatory Reforms And Other Steps To Foster Medtech

Amid repeated calls from industry that South Koreas medical device regulations must catch up with a rapidly changing industry, the country has unveiled measures to reform the rules and nurture the sector, including efforts to accelerate market entry of cutting-edge devices.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT125960

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel